Abstract
Objective
Dietary therapies for irritable bowel syndrome (IBS) have received increasing interest but predicting which patients will benefit remains a challenge due to a lack of mechanistic insight. We recently found evidence of a role for the microbiota in dietary modulation of pain signalling in a humanised mouse model of IBS. This randomised cross-over study aimed to test the hypothesis that pain relief following reduced consumption of fermentable carbohydrates is the result of changes in luminal neuroactive metabolites.Design
IBS (Rome IV) participants underwent four trial periods: two non-intervention periods, followed by a diet low (LFD) and high in fermentable carbohydrates for 3 weeks each. At the end of each period, participants completed questionnaires and provided stool. The effects of faecal supernatants (FS) collected before (IBS FS) and after a LFD (LFD FS) on nociceptive afferent neurons were assessed in mice using patch-clamp and ex vivo colonic afferent nerve recording techniques.Results
Total IBS symptom severity score and abdominal pain were reduced by the LFD (N=25; p<0.01). Excitability of neurons was increased in response to IBS FS, but this effect was reduced (p<0.01) with LFD FS from pain-responders. IBS FS from pain-responders increased mechanosensitivity of nociceptive afferent nerve axons (p<0.001), an effect lost following LFD FS administration (p=NS) or when IBS FS was administered in the presence of antagonists of histamine receptors or protease inhibitors.Conclusions
In a subset of IBS patients with improvement in abdominal pain following a LFD, there is a decrease in pronociceptive signalling from FS, suggesting that changes in luminal mediators may contribute to symptom response.Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/140244608
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1136/gutjnl-2022-327260
Article citations
[Research progress of metabolomics in children with irritable bowel syndrome].
Zhongguo Dang Dai Er Ke Za Zhi, 26(9):989-994, 01 Sep 2024
Cited by: 0 articles | PMID: 39267517 | PMCID: PMC11404471
Review Free full text in Europe PMC
Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome.
EBioMedicine, 107:105282, 22 Aug 2024
Cited by: 0 articles | PMID: 39173527 | PMCID: PMC11388012
Innovative concepts in diet therapies in disorders of gut-brain interaction.
JGH Open, 8(7):e70001, 18 Jul 2024
Cited by: 0 articles | PMID: 39027160 | PMCID: PMC11255864
Review Free full text in Europe PMC
Evolution, adaptation, and new applications of the FODMAP diet.
JGH Open, 8(5):e13066, 20 May 2024
Cited by: 1 article | PMID: 38770353 | PMCID: PMC11103764
Review Free full text in Europe PMC
The gut microbiome in disorders of gut-brain interaction.
Gut Microbes, 16(1):2360233, 01 Jan 2024
Cited by: 0 articles | PMID: 38949979 | PMCID: PMC11218806
Review Free full text in Europe PMC
Go to all (8) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet.
Clin Gastroenterol Hepatol, 20(12):2876-2887.e15, 28 Feb 2022
Cited by: 24 articles | PMID: 35240330
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.
Am J Clin Nutr, 113(6):1531-1545, 01 Jun 2021
Cited by: 28 articles | PMID: 33740048
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
Aliment Pharmacol Ther, 58(4):404-416, 14 Jun 2023
Cited by: 8 articles | PMID: 37313992
Consumption of a Low Fermentable Oligo-, Di-, Mono-saccharides, and Polyols Diet and Irritable Bowel Syndrome: A Systematic Review.
Int J Prev Med, 8:104, 13 Dec 2017
Cited by: 6 articles | PMID: 29416833 | PMCID: PMC5760846
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Allergan Foundation (1)
Grant ID: No number given
American Gastroenterological Association (1)
Grant ID: No number given
Canadian Institutes of Health Research (1)
Grant ID: CNU-158242
Canadian Nutrition Society (1)
Grant ID: CNU-158242
Nestle (1)
Grant ID: CNU-158242
Weston Family Microbiota Initiative (1)
Grant ID: No number given